Search results
Results from the WOW.Com Content Network
People with regular exposure to pigs are at increased risk of swine flu infections. Around the mid-20th century, the identification of influenza subtypes was made possible, allowing accurate diagnosis of transmission to humans. Since then, only 50 such transmissions have been confirmed. These strains of swine flu rarely pass from human to human.
Swine flu is being billed as a potential killer this winter, but health officials still tell us the best public defense is washing our hands. Everyone should get H1N1 flu shots, the feds say, yet ...
Between December 1988 and March 1989, 19 influenza H1N2 virus isolates were identified in 6 cities in China, but the virus did not spread further. [2]A(H1N2) was identified during the 2001–02 flu season (northern hemisphere) in Canada, the U.S., Ireland, Latvia, France, Romania, Oman, India, Malaysia, and Singapore with earliest documented outbreak of the virus occurring in India on May 31 ...
Most flu vaccine companies can not make both seasonal flu vaccine and pandemic flu vaccine at the same time. Production takes months and it is impossible to switch halfway through if health officials make a mistake. If the swine flu mutates, scientists aren't sure how effective a vaccine made now from the current strain will remain. [41]
A number of vaccines have been tested worldwide as authorities rush to stop the spread of the highly contagious disease that ravages pig farms and the $250 billion global pork industry regularly.
For premium support please call: 800-290-4726 more ways to reach us more ways to reach us
Swine influenza (also known as swine flu or pig flu) is a respiratory disease that occurs in pigs that is caused by the Influenza A virus. Influenza viruses that are normally found in swine are known as swine influenza viruses (SIVs). The three main subtypes of SIV that circulate globally are A(H1N1), A(H1N2), and A(H3N2).
[3] [4] Vaccines are categorised into conventional and next generation vaccines. [5] [6] Animal vaccines have been found to be the most cost effective and sustainable methods of controlling infectious veterinary diseases. [6] In 2017, the veterinary vaccine industry was valued at US$7 billion and it is predicted to reach US$9 billion in 2024. [7]